Skip to content

Effect of the Vachaharidradigana kwatha(oral) and Triphaladya taila Matravasti in the management of Medoroga (Hyperlipidemia)

Evaluation of the Clinical Efficacy of Vachaharidradi Gana Kwatha Oral and Triphaladya Taila Matravasti in the Management of Medoroga w s r to Hyperlipidemia - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075360
Enrollment
30
Registered
2024-10-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E782- Mixed hyperlipidemia

Interventions

None listed

Sponsors

Dr Rena Ravali
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having Prathyatma Lakshanas of Medoroga (Kshudra swasa, Trishna, Krathanam, Atinidra, Swedadikya). 2.Ptients having alteration in one or more component of the lipid profile. 3. Triglycerides 150-450mg/dl, Total Cholesterol 200-399 mg/dl, low density lipoprotein 100-190mg/dl 4. Patients indicted for Vasti karma 5. Patients who are willing to participate in the study and agree for consent sign

Exclusion criteria

Exclusion criteria: 1.Patients with uncontrolled Non insulin dependent Diabetes Mellitus, Hypertension and Hypothyroidism. 2.Patients having Congenital hyperlipidemia ( like xanthomas ) ,Systemic disorders, Chronic kidney diseases, Drug induced hyperlipidemia eg; glucocorticoids etc. and who is suffering from HIV, Carcinoma. 3.Known gene mutations are excluded. 4.Pregnant women and lactating mothers. 5.Patients contraindicated for vasti karma.

Design outcomes

Primary

MeasureTime frame
To reduce the symptoms of HyperlipidemiaTimepoint: 90 days

Secondary

MeasureTime frame
To Reduce raised Total cholesterols, triglycerides, LDL CountsTimepoint: 90 days

Countries

India

Contacts

Public ContactDr Neredu Uma Srinivas Rao

Dr BRKR Govt Ayurvedic Medical College &Hospital

dr.nusrao@gmail.com9246346346

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026